| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/06/2009 | US7597849 Evidence collection holder for sample automation |
| 10/06/2009 | US7597814 Structure formed with template having nanoscale features |
| 10/06/2009 | US7597362 Plug-in connector for tube and hose lines with catch spring guide |
| 10/06/2009 | CA2529430C Biosensor and method of making |
| 10/06/2009 | CA2470465C Improved biosensor and method |
| 10/06/2009 | CA2388811C Techniques for growth and differentiation of human pluripotent stem cells |
| 10/06/2009 | CA2384278C Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups |
| 10/06/2009 | CA2381323C Amyloid .beta. protein (globular assembly and uses thereof) |
| 10/06/2009 | CA2311952C Fluorimetric detection system of a nucleic acid |
| 10/06/2009 | CA2284689C Animal model for evaluation of vaccines |
| 10/06/2009 | CA2257109C Monitoring hybridization during pcr |
| 10/06/2009 | CA2218448C Raffinose synthase genes and their use |
| 10/06/2009 | CA2159106C Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 10/04/2009 | CA2625304A1 Androgen receptor related methods for treating bladder cancer |
| 10/01/2009 | WO2009121079A2 Test device and method for testing for vaginal infections |
| 10/01/2009 | WO2009121070A1 Multifactorial methods for detecting lung disorders |
| 10/01/2009 | WO2009121044A1 Impaired alleles of genes involved in metabolic pathways and methods for detecting and using the same |
| 10/01/2009 | WO2009121031A1 Methods of novel therapeutic candidate identification through gene expression analysis in vascular-related diseases |
| 10/01/2009 | WO2009121028A1 Compositions and methods for reusing arrays |
| 10/01/2009 | WO2009121021A1 Degradable arrays for preventing reuse |
| 10/01/2009 | WO2009120963A2 Paper-based cellular arrays |
| 10/01/2009 | WO2009120905A2 Immunoglobulin and/or toll-like receptor proteins associated with myelogenous haematological proliferative disorders and uses thereof |
| 10/01/2009 | WO2009120903A2 Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof |
| 10/01/2009 | WO2009120877A2 Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases |
| 10/01/2009 | WO2009120808A2 Restriction endonuclease enhanced polymorphic sequence detection |
| 10/01/2009 | WO2009120802A2 Methods and compositions for identifying biomarkers useful in characterizing biological states |
| 10/01/2009 | WO2009120800A2 Prognostic panel for urinary bladder cancer |
| 10/01/2009 | WO2009120795A1 Methods of chemotype evolution |
| 10/01/2009 | WO2009120767A1 A method for detecting igf1r/chr 15 circulating tumor cells using fish |
| 10/01/2009 | WO2009120763A2 Genetic polymorphisms and infertility |
| 10/01/2009 | WO2009120755A1 Multiplex screening for pathogenic hypertrophic cardiomyopathy mutations |
| 10/01/2009 | WO2009120557A2 Nanoparticle-mediated signal amplification |
| 10/01/2009 | WO2009120532A2 Spectral analysis of biological growth media |
| 10/01/2009 | WO2009120374A2 Methods and compositions for nucleic acid sample preparation |
| 10/01/2009 | WO2009120372A2 Compositions and methods for nucleic acid sequencing |
| 10/01/2009 | WO2009120341A2 Biomarkers for predicting response to immunosuppressive therapy |
| 10/01/2009 | WO2009120313A2 Identification of human t2r receptors that respond to bitter ligands in soy and related assays for identifying bitter taste modulators |
| 10/01/2009 | WO2009120249A1 Detection of head and neck cancer using hypermethylated gene detection |
| 10/01/2009 | WO2009120186A1 Methods and compositions for treating atherosclerosis and related conditions |
| 10/01/2009 | WO2009120183A2 System for the detection of a biological pathogen and use thereof |
| 10/01/2009 | WO2009119965A1 Allosteric trans-splicing group i ribozyme whose activity of target-specific rna replacement is controlled by theophylline |
| 10/01/2009 | WO2009119915A1 Plant disease resistance inducer |
| 10/01/2009 | WO2009119891A1 Method for determination of dna methylation |
| 10/01/2009 | WO2009119890A1 Method for determination of dna methylation |
| 10/01/2009 | WO2009119809A1 Marker for determination of breast cancer, test method, and test kit |
| 10/01/2009 | WO2009119728A1 Flavin adenine dinucleotide dependent glucose dehydrogenase (fadgdh) derived from filamentous fungus |
| 10/01/2009 | WO2009119647A1 Method for fluorescence labeling of nucleic acid |
| 10/01/2009 | WO2009119502A1 Method for evaluation of degree of malignancy of tumor cell |
| 10/01/2009 | WO2009119331A1 REAGENT COMPRISING PRIMER FOR DETECTION OF mRNA FOR CYTOKERATIN-7 |
| 10/01/2009 | WO2009119330A1 Method for analyzing image for cell observation, image processing program, and image processing device |
| 10/01/2009 | WO2009119329A1 Method for analyzing image for cell observation, image processing program, and image processing device |
| 10/01/2009 | WO2009118928A1 Efficient production and use of highly cardiogenic progenitors and cardiomyocytes from embryonic and induced pluripotent stem cells |
| 10/01/2009 | WO2009118301A1 Centrosome-assay |
| 10/01/2009 | WO2009118204A2 Medicament, compositions, and substances for treating and identifying adenocarcinoma of the lung |
| 10/01/2009 | WO2009118192A1 Methods and materials for the reproducible generation of high producer cell lines for recombinant proteins |
| 10/01/2009 | WO2009118157A1 Biosensor with improved analyte specificity |
| 10/01/2009 | WO2009118137A1 Use of cathepsin c |
| 10/01/2009 | WO2009117811A1 Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor |
| 10/01/2009 | WO2009117798A2 Fluorescent nanoparticle composites themselves, process for the preparation of such composites, and use in rapid diagnosis systems with affinity to biological molecules |
| 10/01/2009 | WO2009117773A1 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof |
| 10/01/2009 | WO2009100430A3 miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS |
| 10/01/2009 | WO2009100161A3 Epigenetic silencing of mir-342 in colorectal cancer |
| 10/01/2009 | WO2009099941A3 Sequences associated with tdp-43 proteinopathies and methods of using the same |
| 10/01/2009 | WO2009094597A3 Use of nucleic acid probes to detect nucleotide sequences of interest in a sample |
| 10/01/2009 | WO2009090330A3 Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections |
| 10/01/2009 | WO2009088987A3 Compositions and methods for polynucleotide extraction and methylation detection |
| 10/01/2009 | WO2009082445A3 Novel devices for the detection of the presence and/or activity of proteases in biological samples |
| 10/01/2009 | WO2009080899A3 Products and methods affecting cell and tissue growth |
| 10/01/2009 | WO2009079450A3 Copy number alterations that predict metastatic capability of human breast cancer |
| 10/01/2009 | WO2009049015A9 Identification method for electrochemical test strips |
| 10/01/2009 | WO2009045632A3 Nucleic acid based fluorescent sensor for mercury detection |
| 10/01/2009 | WO2009030225A3 Marker sequences for multiple sclerosis and use thereof |
| 10/01/2009 | WO2008140484A3 Methods for diagnosing and monitoring the status of systemic lupus erythematosus |
| 10/01/2009 | WO2008017636A8 Genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 10/01/2009 | US20090249505 Methods for producing a hybrid seed product |
| 10/01/2009 | US20090249502 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer; antibody or antigen-binding fragment thereof that specifically binds to a 193P1E1B protein; drug delivery |
| 10/01/2009 | US20090249500 System for monitoring bacterial tumor treatment |
| 10/01/2009 | US20090249499 Sperm-specific cation channel, catsper4, and uses therefor |
| 10/01/2009 | US20090249498 Methods of diagnosing alzheimer's disease and markers identified by set association |
| 10/01/2009 | US20090248450 Integrated Biosensor and Simulation System for Diagnosis and Therapy |
| 10/01/2009 | US20090248316 Method for supporting a diagnosis of an effect of a treatment by using anthracycline anticancer drugs and a device for supporting a diagnosis for an effect of a treatment by using anthracycline anticancer drugs |
| 10/01/2009 | US20090247733 Novel Bone Mineralization Proteins, DNA, Vectors, Expression Systems |
| 10/01/2009 | US20090247634 Methods for identifying modulators of eoxin formation |
| 10/01/2009 | US20090247627 Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists |
| 10/01/2009 | US20090247609 Sm-protein based secretion engineering |
| 10/01/2009 | US20090247605 Treating diseases mediated by metalloprotease-shed proteins |
| 10/01/2009 | US20090247576 Anti-tumor agent for multiple myeloma |
| 10/01/2009 | US20090247538 Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors |
| 10/01/2009 | US20090247475 Methods and compositions relating to pharmacogenetics of different gene variants in the context of irinotecan-based therapies |
| 10/01/2009 | US20090247455 Isolation of Inhibitors of IRES-Mediated Translation |
| 10/01/2009 | US20090247454 Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease |
| 10/01/2009 | US20090247422 In SITU Induced Antigen Technology (ISIAT) for Identification of Polynucleotides Expressed during Infection or Colonization |
| 10/01/2009 | US20090247414 Method and device for nucleic acid sequencing using a planar waveguide |
| 10/01/2009 | US20090246859 Methods and Compositions for Purification of Nucleic Acid from a Host Cell |
| 10/01/2009 | US20090246853 Directed evolution method |
| 10/01/2009 | US20090246829 Sequence analysis of the tetravalent rotavirus vaccine |
| 10/01/2009 | US20090246823 Evaluation methodology of the protection characteristics of personal protective equipments against biological agents |
| 10/01/2009 | US20090246822 Composition for cell permeabilization comprising NOG, HMP, rubidium chloride and/or lithium chloride for detecting living cells on a membrane |
| 10/01/2009 | US20090246821 Peroxiredoxin drugs for treatment of hiv-1 infection and methods of use thereof |
| 10/01/2009 | US20090246820 Compounds useful in cftr assays and methods therewith |